Evidence map›Paper›PMID 21244368›Full record

ArticleBritish journal of pharmacology2011

Regulation of renal sympathetic neurotransmission by renal α(2A)-adrenoceptors is impaired in chronic renal failure.

Henning Hoch, Johannes Stegbauer, Sebastian A Potthoff, Lutz Hein, Ivo Quack, Lars Christian Rump, Oliver Vonend

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Presynaptic Adrenoceptors.Handbook of experimental pharmacology · 2024
    Review
  2. Review
  3. Journal of the American Society of Nephrology : JASN · 2020
    Article
  4. Review
  5. Review
  6. Renal sympathetic nerve activation via αKidney research and clinical practice · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Henning HochDepartment of Nephrology, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany. henning.hoch@med.uni-duesseldorf.de
Johannes Stegbauer
Sebastian A Potthoff
Lutz Hein
Ivo Quack
Lars Christian Rump
Oliver Vonend
Heinrich Heine University Düsseldorf · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe mechanisms underlying increased renal noradrenaline in renal failure are still unclear. In this study, the role of α(2A)-adrenoceptors in controlling sympathetic neurotransmission in chronic renal failure was evaluated in a subtotal nephrectomy model. Also, the influence of this receptor subtype on angiotensin II (Ang II)-mediated noradrenaline release was evaluated. EXPERIMENTAL APPROACH: α(2A)-adrenoceptor-knockout (KO) and wild-type (WT) mice underwent subtotal (5/6) nephrectomy (SNx) or SHAM-operation (SHAM). Kidneys of WT and KO mice were isolated and perfused. Renal nerves were stimulated with platinum electrodes and noradrenaline release was measured by HPLC. KEY

resultsNoradrenaline release induced by renal nerve stimulation (RNS) was significantly increased in WT mice after SNx. RNS-induced noradrenaline release was significantly higher in SHAM-KO compared with SHAM-WT, but no further increase in noradrenaline release could be observed in SNx-KO. α-adrenoceptor antagonists increased RNS-induced noradrenaline release in SHAM-WT but not in SHAM-KO. After SNx, the effect of α₂-adrenoceptor blockade on renal noradrenaline release was attenuated in WT mice. The mRNA expression of α(2A)-adrenoceptors was not altered, but the inhibitory effect of α₂-adrenoceptor agonists on cAMP formation was abolished after SNx. Ang II facilitated RNS-induced noradrenaline release in SHAM-WT but not in SHAM-KO and SNx-WT. CONCLUSION AND IMPLICATIONS: In our model of renal failure autoregulation of renal sympathetic neurotransmission was impaired. Presynaptic inhibition of noradrenaline release was diminished and the facilitatory effect of presynaptic angiotensin AT₁ receptors on noradrenaline release was markedly decreased in renal failure and depended on functioning α(2A)-adrenoceptors.

Indexed as

Adrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-2 Receptor AntagonistsAngiotensin IIAnimalsCyclic AMPElectric StimulationKidneyKidney Failure, ChronicMiceMice, KnockoutNorepinephrineReceptor, Angiotensin, Type 1Receptors, Adrenergic, alpha-2Receptors, PresynapticSympathetic Nervous SystemSynaptic TransmissionAdra2a protein, mouseAdra2b protein, mouseAdra2c protein, mouseAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-2 Receptor AntagonistsAngiotensin IICyclic AMPNorepinephrineReceptor, Angiotensin, Type 1Receptors, Adrenergic, alpha-2Receptors, Presynaptic

Identifiers

PMID21244368
PMCPMC3087143
OpenAlexW1548297656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.